Yuhan and Johnson & Johnson Innovative Medicine (JJIM), formerly known as Janssen, ended a research project after securing ...

In the latest supply deal on the active pharmaceutical ingredients (API) front, Gilead Sciences has tapped South Korea’s ...

Approvals are coming fast and furious for Johnson & Johnson’s Rybrevant as it is lining up to challenge the dominance of ...

British brands Burberry, JW Anderson and Mark Fast plus emerging talent Chet Lo, and Feben were among 72 designers at one of ...

Asian stocks closed broadly higher on Friday, although most of the markets in the region turned a bit subdued and pared early gains ...

Asian markets ended the trading week on a positive note, with Japan’s Nikkei leading gains after a strong performance on Wall ...

South Korean pharmaceutical giant Yuhan announced Friday it has terminated its collaboration with Janssen Biotech on the ...

Such policies can compensate natural disaster victims and drive climate action, but insurers and consumers are cautious.

Yuhan sealed a $80.9 million deal with California-based Gilead Sciences to supply pharmaceutical ingredients for the ...

Plenty of that this season of course. Plus the frothy femininity was particularly good (it helps when Simone Rocha, Yuhan ...

From New York to Paris and the fashion capitals in between, there’s no shortage of fresh talent this season and we are ...

Now in it’s fourth decade, the city’s biggest fashion event was certainly a time for reflection — particularly against the ...